Finally, many times empyema will be loculated and the pleural fluid aspirate may represent only a sterile inflammatory area adjacent to an infected loculation (Figure 12-1).

LTI-01 is currently in a Phase 2, randomized, placebo-controlled, double-blind, dose-ranging study evaluating LTI-01 in patients with infected, non-draining loculated pleural effusions.